TORNTPHARM — Torrent Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.13tn
- IN₹1.15tn
- IN₹107.28bn
- 100
- 9
- 57
- 59
Annual balance sheet for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,623 | 7,380 | 5,830 | 7,228 | 10,040 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19,957 | 18,956 | 19,216 | 22,371 | 21,948 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49,809 | 55,232 | 52,947 | 53,292 | 56,115 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 35,299 | 36,288 | 32,469 | 34,598 | 35,778 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 140,097 | 140,747 | 130,998 | 150,119 | 150,606 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 54,542 | 48,916 | 44,151 | 54,473 | 54,253 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 91,865 | 82,375 | 71,469 | 88,138 | 82,044 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 48,232 | 58,372 | 59,530 | 61,981 | 68,562 |
Total Liabilities & Shareholders' Equity | 140,097 | 140,747 | 130,998 | 150,119 | 150,606 |
Total Common Shares Outstanding |